Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma (Q45151875)

10 December 2017

Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma (English)

1 reference

10 December 2017

Eva Villamón

1

1 reference

10 December 2017

Marta Piqueras

2

1 reference

10 December 2017

Carlos Mackintosh

3

1 reference

10 December 2017

Javier Alonso

4

1 reference

10 December 2017

Enrique de Alava

5

1 reference

10 December 2017

Samuel Navarro

6

1 reference

10 December 2017

Rosa Noguera

7

1 reference

10 December 2017

language of work or name

1 reference

24 June 2008

1 reference

10 December 2017

1 reference

10 December 2017

453

1 reference

10 December 2017

1

1 reference

10 December 2017

47-55

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-008-0633-6

10 December 2017

0 references

cites work

Neuroblastoma tumour genetics: clinical and biological aspects

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-008-0633-6

Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-008-0633-6

[Neuroblastoma; biology and prognostic factors]

21 January 2018

1 reference

12 December 2020

Chromosome 1p and 11q deletions and outcome in neuroblastoma

1 reference

12 December 2020

Deletion of chromosome 11 and of 14q sequences in neuroblastoma

1 reference

12 December 2020

Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients.

1 reference

12 December 2020

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study

1 reference

12 December 2020

Molecular biology of neuroblastoma

1 reference

12 December 2020

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

1 reference

12 December 2020

Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma

1 reference

12 December 2020

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.

1 reference

12 December 2020

Quality assessment of genetic markers used for therapy stratification.

1 reference

12 December 2020

Mechanisms of invasion and metastasis in human neuroblastoma

1 reference

12 December 2020

Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma

1 reference

12 December 2020

Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

1 reference

12 December 2020

[Genomic profile in high risk neuroblastoma by comparative genomic hybridization]

1 reference

12 December 2020

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

12 December 2020

Human neuroblastoma I-type cells are malignant neural crest stem cells

1 reference

12 December 2020

Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization

1 reference

12 December 2020

MYCN gain and MYCN amplification in a stage 4S neuroblastoma

1 reference

12 December 2020

Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method

1 reference

12 December 2020

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

1 reference

12 December 2020

Investigation of MYCN status in neuroblastoma by fluorescence in situ hybridization

1 reference

12 December 2020

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

1 reference

12 December 2020

Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in Neuroblastoma

1 reference

12 December 2020

MYCN amplification remains prognostically strong 20 years after its “clinical debut”

1 reference

12 December 2020

Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus

1 reference

12 December 2020

Clinical impact of chromosome 1 aberrations in neuroblastoma: a metaphase and interphase cytogenetic study

1 reference

12 December 2020

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

1 reference

12 December 2020

Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses

1 reference

12 December 2020

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number

1 reference

12 December 2020

Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.

1 reference

12 December 2020

Loss of chromosome 1p may have a prognostic value in localised Neuroblastoma: results of the French NBL 90 study

1 reference

12 December 2020

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

12 December 2020

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors

1 reference

12 December 2020

Neuroblastoma: biological insights into a clinical enigma

1 reference

12 December 2020

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

1 reference

12 December 2020

Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping

1 reference

12 December 2020

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

1 reference

12 December 2020

Frequent loss of heterozygosity on chromosome 14q in neuroblastoma

1 reference

12 December 2020

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma

1 reference

12 December 2020

Loss of heterozygosity for chromosome 14q in neuroblastoma

1 reference

12 December 2020

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification

1 reference

12 December 2020

Allelic imbalance on chromosome 18 in neuroblastoma

1 reference

12 December 2020

Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.

1 reference

12 December 2020

Characterization of karyotypic events and evolution in neuroblastoma

1 reference

12 December 2020

Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma

1 reference

12 December 2020

Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification

1 reference

12 December 2020

Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry

1 reference

12 December 2020

Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.

1 reference

12 December 2020

The biologic basis for neuroblastoma heterogeneity and risk stratification

1 reference

12 December 2020

Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR

1 reference

12 December 2020

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

12 December 2020

Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

1 reference

12 December 2020

Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma

1 reference

12 December 2020

High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays

1 reference

12 December 2020

Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.

1 reference

12 December 2020

10.1007/S00428-008-0633-6

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference